Published in Maroc Med on March 01, 1985
Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob Agents Chemother (2001) 1.72
Dorsal plating for displaced intra-articular fractures of the distal radius. Injury (2003) 1.67
The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol (2012) 1.39
[Role of surgery in the treatment of Pott's disease in adults. Apropos of 29 cases]. Rev Chir Orthop Reparatrice Appar Mot (1996) 1.37
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus. Antimicrob Agents Chemother (2002) 1.26
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed Pharmacother (1994) 1.23
Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro. Antimicrob Agents Chemother (1994) 1.23
Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab (2007) 1.16
Medical decompression of vertebral hydatidosis. Spine (Phila Pa 1976) (1997) 1.16
Antiviral beta-L-nucleosides specific for hepatitis B virus infection. Antivir Chem Chemother (2001) 1.12
Inhibition of mammalian DNA polymerase-associated 3' to 5' exonuclease activity by 5'-monophosphates of 3'-azido-3'-deoxythymidine and 3'-amino-3'-deoxythymidine. Biochem Pharmacol (1993) 1.12
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol (2000) 1.09
MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. J Immunol (2001) 1.01
Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells. Biochem Pharmacol (1997) 1.01
Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab (2006) 1.00
Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa. Protein Sci (1994) 0.98
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol (2005) 0.97
Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol (1999) 0.97
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol (2000) 0.96
[Hydatid cyst of the pancreas]. J Chir (Paris) (2005) 0.95
[Etiologic factors in primary bronchial carcinoma in Tunisia]. Tunis Med (1993) 0.93
[Tuberculosis of the talus: a rare localization of Koch's bacillus]. Rev Chir Orthop Reparatrice Appar Mot (2002) 0.91
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur J Immunol (2001) 0.91
Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett (1998) 0.90
[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)]. C R Acad Sci III (1986) 0.89
Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Eur J Immunol (1986) 0.89
Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol (1995) 0.89
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategy. J Acquir Immune Defic Syndr (1992) 0.87
[Scorpion sting and acute interstitial nephropathy: Apropos of 1 case]. Med Trop (Mars) (2000) 0.87
[Tuberculosis of the patella. An unusual localization apropos of 2 cases]. J Chir (Paris) (1995) 0.87
[Necrosis of the glans penis]. Rev Med Interne (2010) 0.87
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A (1993) 0.86
Hydatid cyst of the rib: a new case and review of the literature. Case Rep Med (2010) 0.86
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Int Immunol (1998) 0.86
Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol (1995) 0.85
[Desmoid cervical tumour following the placing of an internal jugular catheter]. Presse Med (2004) 0.84
Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs. Nucleic Acids Res (1999) 0.83
[Chylothorax after superior vena cava thrombosis in Behçet's disease]. Presse Med (1985) 0.83
Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease. Pathol Biol (Paris) (2011) 0.83
[Benign granular cell anal tumor]. Presse Med (2003) 0.82
[Neglected spontaneous bilateral rupture of the patellar tendon: a case report]. Rev Chir Orthop Reparatrice Appar Mot (2003) 0.82
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed Pharmacother (1994) 0.82
Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2. Virus Res (1999) 0.82
[Isolated retroperitoneal hydatid cyst. Apropos of 2 new cases]. J Urol (Paris) (1983) 0.82
Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft. Eur J Immunol (1998) 0.82
[Level of cardiovascular risk factors in the urban and rural populations of Cap-Bon: Tunisia]. Rev Epidemiol Sante Publique (1996) 0.82
Hemolytic uremic syndrome and prostatic adenocarcinoma. Clin Nephrol (1987) 0.82
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Virology (2000) 0.81
[Incidence of surgical wound infections a prospective study in the Rabat Mohamed-V military hospital, Morocco]. Med Mal Infect (2005) 0.81
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? Cell Death Differ (1995) 0.81
[Primary non-Hodgkin's malignant lymphoma of the adrenal gland. Case report and review of the literature]. Prog Urol (1999) 0.81
[A rare cause of acute intestinal obstruction: transmesenteric hernia of the small intestine and the sigmoid loop]. Lyon Chir (1972) 0.81
Synthesis and antiviral evaluation of SATE-foscarnet prodrugs and new foscarnet-AZT conjugates. Antivir Chem Chemother (1998) 0.80
NDP kinase reactivity towards 3TC nucleotides. Antiviral Res (2001) 0.80
A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. J Acquir Immune Defic Syndr (1992) 0.80
[High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia]. Pathol Biol (Paris) (2004) 0.80
"Kinoids": the basis for anticytokine immunization and their use in HIV infection. Cell Mol Biol (Noisy-le-grand) (1995) 0.80
Automat: a novel software system for the systematic search for protein (or DNA) similarities with a notable application to autoimmune diseases and AIDS. Comput Appl Biosci (1994) 0.80
Does position of syndesmotic screw affect functional and radiological outcome in ankle fractures? Injury (2005) 0.80
Enhanced dendritic cell-driven proliferation and anti-HIV activity of CD8(+) T cells by a new phenothiazine derivative, aminoperazine. J Immunol (2001) 0.80
Automat and BLAST: comparison of two protein sequence similarity search programs. Comput Appl Biosci (1995) 0.79
[Primary hypothyroidism and glomerular involvement]. Ann Endocrinol (Paris) (1991) 0.79
[Fractures of the trapezium]. Acta Orthop Belg (2000) 0.79
Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum Exp Toxicol (1999) 0.78
[Food intake and energy expenditure in high school athletes before, during and after the month of Ramadan: effect of fasting on performance]. Tunis Med (1993) 0.78
Anti-HBV specific beta-L-2'-deoxynucleosides. Nucleosides Nucleotides Nucleic Acids (2001) 0.78
Stereospecific synthesis and biological evaluations of beta-L-pentofuranonucleoside derivatives of 5-fluorouracil and 5-fluorocytosine. Eur J Med Chem (2001) 0.78
Effect of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil on mitochondrial functions in HepG2 cells. Antiviral Res (1999) 0.78
[Surgical management of isolated fractures of the ulnar shaft]. Acta Orthop Belg (2002) 0.78
Cloning, expression, purification, crystallization and preliminary X-ray analysis of the pilus-associated sortase C from Streptococcus pneumoniae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.78
Removal of gp160 induced bio-hazards for a safe AIDS vaccine candidate. Biomed Pharmacother (1992) 0.77
HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed Pharmacother (1993) 0.77
Structural determinants of HIV-1 reverse transcriptase stereoselectivity towards (beta)-L-deoxy- and dideoxy-pyrimidine nucleoside triphosphates: molecular basis for the combination of L-dideoxynucleoside analogs with non-nucleoside inhibitors in anti HIV chemotherapy. Nucleosides Nucleotides (1999) 0.77
Enhancement of cyclosporine A nephrotoxicity by diclofenac. Clin Nephrol (1987) 0.77
[Serum copper levels in obesity: a study of 32 cases]. Tunis Med (2001) 0.77
The predictors of early mortality in patients starting chronic hemodialysis. Saudi J Kidney Dis Transpl (2007) 0.77
Cyclosporine A treatment for human immunodeficiency virus-infected transplant recipients. Transplant Proc (1987) 0.77
The role of an exposed loop in the alpha2 domain in the mouse MHC class I H-2Dd molecule for recognition by the monoclonal antibody 34-5-8S and the NK-cell receptor Ly49A. Scand J Immunol (2002) 0.77
Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2. Viral Immunol (1999) 0.77
Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report. Transplant Proc (2003) 0.76
[Comparative effects of the WHO solution and of a simplified solution in infants with acute diarrhea]. Ann Pediatr (Paris) (1985) 0.76
[Epidemiology of diabetes in Tunisia]. Tunis Med (1998) 0.76
[Ochratoxin A genotoxicity, relation to renal tumors]. Arch Inst Pasteur Tunis (1995) 0.75
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotides. Antiviral Res (2000) 0.75
HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells. AIDS (1999) 0.75
Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS. Biomed Pharmacother (1993) 0.75
Polymerase chain reaction amplified HTLV-I, HIV-1 and HIV-2 DNA fragments in subjects with mixed retroviral infections. J Med Microbiol (1993) 0.75
Critical sites: a semantic approach to protein sequences. Application to the HIV-1 envelope molecule. Biomed Pharmacother (1992) 0.75
[Diabetic ketosis and ketoacidosis]. Tunis Med (1999) 0.75
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomed Pharmacother (1992) 0.75
[Nutritional intakes in a group of infants aged six to fourteen months]. Tunis Med (1999) 0.75
[Collecting - setting up. Initial evacuation]. Maroc Med (1985) 0.75
[Quality of care in the hospital: between reality and user perceptions. Results of a survey done in Tunis]. Tunis Med (1992) 0.75
[The diabetic's mouth]. Tunis Med (1998) 0.75